Stallion India Fluorochemicals Approves Rights Issue of ₹364 Crore
Stallion India Fluorochemicals' Board approved a Rights Issue of up to ₹364 Crore. The issue will be of Equity Shares with a face value of Rs. 10.00/- each, offered to eligible shareholders on a record date to be determined. A Rights Issue Committee has been formed to manage the process.
A rights issue of this magnitude can significantly impact the company's capital structure and shareholder equity, hence a medium impact.
The approval of a rights issue to raise capital indicates a positive step for the company's growth and operational expansion.
Stallion India Fluorochemicals Limited announced the outcome of its Board Meeting held on Friday, 23rd January, 2026. The Board approved a Rights Issue of Equity Shares aggregating up to ₹364.00 Crores (Rupees Three Hundred Sixty-Four Crores Only).
The Equity Shares will have a face value of Rs. 10.00/- each and will be issued for cash at an Issue Price of Rs. [•] per Equity Share. The issue is open to eligible equity shareholders of the Company as on a Record date, which is yet to be determined by the Board.
A Committee of Directors, to be known as the “Rights Issue Committee”, has been formed to manage all aspects of the Rights Issue. This includes determining and altering the treatment of fractional entitlements, making necessary applications to regulatory authorities, and finalizing the terms, conditions, structure, and timing of the Rights Issue.
The company's outstanding equity shares before the Rights Issue were 7,93,25,254 Equity Shares of Rs. 10.00/- each. The full amount per Equity Share is payable on application by eligible equity shareholders. Further details regarding the issue structure, including the issue price, number of Equity Shares offered, and the rights entitlement ratio, will be disclosed in the final Letter of Offer.
What to do with a filing like this
Stallion India Fluorochemicals Limited filed this with the NSE as a statutory disclosure, categorised under rights issue. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Stallion India Fluorochemicals Limited. Read the original for the full detail.